Delta4’s Year in Review: Strong Momentum in 2025 Fuels Ambitious Plans for 2026
As 2025 draws to a close, Delta4 reflects on a remarkable year of scientific achievement, strategic partnerships, and technological advancement. From securing national recognition to publishing cutting-edge research and advancing major EU initiatives, Delta4 has demonstrated that AI-powered drug discovery, grounded in rigorous computational biology, is not only possible but scalable and impactful. “2025 has […]
Delta4 Announces Prof. Doron Lancet To Join Scientific Advisory Board
VIENNA, Austria, March 6th, 2023 — Delta4, a digital drug discovery company focusing on the identification of new indications for existing drug compounds, today announced that Prof. Doron Lancet will join its Scientific Advisory Board. Prof. Lancet is a distinguished scientist in the area of genetics and systems biology. “We are excited to have Prof. […]
Delta4 Announces Dr. Hans Lehrach to Join Scientific Advisory Board
VIENNA, Austria, September 27th, 2021 — Delta4, a digital drug discovery company focusing on the identification of new indications for existing drug compounds, today announced that Dr. Hans Lehrach will join its Scientific Advisory Board. Prof. Lehrach is a distinguished scientist in the area of genomics. „We are excited to have Dr. Lehrach join our […]